Possible graft-versus-host reaction after intrauterine transfusion for Rh erythroblastosis fetalis.
D000741:Anemia, Aplastic / Q000209:etiology; D001772:Blood Cell Count; D001805:Blood Transfusion, Intrauterine / Q000009:adverse effects*; D001854:Bone Marrow Cells; D004899:Erythroblastosis, Fetal / Q000628:therapy*; D005260:Female; D006086:Graft vs Host Disease / Q000209:etiology* / Q000473:pathology; D006644:Histiocytes; D006648:Histocompatibility; D006650:Histocompatibility Testing; D006801:Humans; D007231:Infant, Newborn; D007565:Jaundice / Q000209:etiology; D008214:Lymphocytes / Q000166:cytology; D008297:Male; D011247:Pregnancy; D012204:Rh-Hr Blood-Group System; D012730:Sex Chromosomes; D013950:Thymus Gland / Q000473:pathology; D014181:Transplantation Immunology
D012204:Rh-Hr Blood-Group System